← Insider buys
AVIR

Atea Pharmaceuticals, Inc. · Healthcare

Director Bruce Polsky sold $61K of Atea Pharmaceuticals, Inc.

Sold$61,144
$3.49Price
17,544Shares
−21%Stake

What AVIR did after the filing

Filed Jun 21, copier in the same day
The stock from Fri, Jun 21 close, $3.44
−4.7%
S&P 500, same days
−5.0%

Measured over 30 trading days, to the Aug 5 close.

Traded Thu, Jun 20. Filed Fri, Jun 21, 1:59 PM ET, during the session. Returns use the Jun 21 close and the Aug 5 close. Not investment advice.